MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0023186
Aeon Formulations Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.33 Cr
▼ 16% YoY
Net loss · FY 2025
₹2.42 Cr
Net margin -9.9%
EBITDA · FY 2025
-₹45.19 Lakh
EBITDA margin -1.9%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.95 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹10.12 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
86
Provident fund records
About Aeon Formulations Private Limited
Data last updated:
Aeon Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33110TN2008PTC069867. Its GSTIN is 33AAHCA4128R1ZE (Tamil Nadu). The company holds 7 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.95 Cr. It is led by directors including Vijayarani Vaitheeswaran and Ariarasudhan Vaitheeswaran.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.33 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹2.42 Cr (net margin -9.9%) and EBITDA of -₹45.19 Lakh (EBITDA margin -1.9%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 11% over five years.
The company has about 86 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aeon Formulations. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹10.12 Cr on record. Court records list 40 cases involving the company, including 22 filed by the company and 18 filed against it; 16 cases are pending.
Aeon Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0023186). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aeonf.com.
Company details
CIN U33110TN2008PTC069867
Registration Number 069867
Incorporation Date 17 November 2008
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0023186
Key People
Vijayarani Vaitheeswaran Director Ariarasudhan Vaitheeswaran Director Sathyamurthy Jayavardhini Additional Director Recognitions & Rankings of Aeon Formulations
Contact details
Aeon Formulations Private Limited's registered office is in Chennai, Tamil Nadu. Its website is aeonf.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 21 Door No 2 Velu Naicker Street Near Kattbomman Street Venkateswaranagar, Ramapuram, Chennai, Tamil Nadu, India – 600089
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aeon Formulations Private Limited, buy the company report.
Comprehensive company report
Aeon Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aeon Formulations operates one associated brand: Aeon Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, healthcare services, and agritech operations in India. | aeonf.com |
Business activity
The main business activity of Aeon Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aeon Formulations Private Limited, buy the company report.
Financials of Aeon Formulations Private Limited
FY 2025 filings availableAeon Formulations Private Limited reported revenue of ₹24.33 Cr (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹24.33 Cr ▼ 16%
Net loss · FY 2025
₹2.42 Cr margin -9.9%
EBITDA · FY 2025
-₹45.19 Lakh margin -1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 11%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 283%
3 years · compounded
▼ 29%
5 years · compounded
▼ 18%
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 16% fall in the latest year. EBITDA fell 283% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹45.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.9% | ||||
| Net Profit Margin | -9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aeon Formulations Private Limited, buy the company report.
Board of directors of Aeon Formulations Private Limited
Aeon Formulations has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijayarani Vaitheeswaran Also directs: Eesun Enterprises India Private Limited | Director | 17 Feb 2014 | 12 Years 8 Months | Current |
| Ariarasudhan Vaitheeswaran Also directs: Aeobiome Healthcare Private Limited | Director | 05 Mar 2020 | 6 Years 7 Months | Current |
| Sathyamurthy Jayavardhini | Additional Director | 11 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Aeon Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | 92.0% | Chennai, Tamil Nadu, India | |||
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Kemecos India Pvt Ltd | ₹24.35 Cr (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Aeon Formulations Private Limitedthis company | ₹24.33 Cr (FY 2025) | -₹2.42 Cr | -9.9% | -16.0% | 86 | Chennai, Tamil Nadu, India |
| Axacus Pharma Private Limited | ₹24.29 Cr (FY 2024) | 37.0% | Ahmedabad, Gujarat, India | |||
| Chemifine Formulations Private Limited | ₹24.25 Cr (FY 2024) | -10.0% | Nellore, Andhra Pradesh, India | |||
| Sunvij Drugs Private Limited | ₹24.23 Cr (FY 2024) | 24.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Aeon Formulations Private Limited, buy the company report.
Auditor
Aeon Formulations Private Limited is audited by V M B G & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V M B G & Co | FY 2024 | 016564S |
Shareholding
The shareholding of Aeon Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aeon Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6 Cr
Satisfied charges
₹10.12 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 May 2024 | 100928092 | Others | ₹6 Cr | Open | |
| 06 Jan 2012 | 10333251 | Canara Bank | ₹10.07 Cr | Satisfied | |
| 31 Oct 2009 | 10221595 | Indian Bank | ₹5 Lakh | Satisfied |
To see the full charge records of Aeon Formulations Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Aeon Formulations Private Limited has 40 court cases on record: 22 filed by Aeon Formulations, 18 filed against it. 16 cases are pending and 24 are disposed.
Total cases
40
Filed by the company
22
Filed against the company
18
Pending
16
Disposed
24
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 26 | 6 | 5 |
| High courts | 14 | 12 | 11 |
Cases on record (5 of 40)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed by the company against VRL Logistics Ltd and 1 other | Disposed |
| District court, Muzaffarpur, Bihar | Court case (Drugs and Cosmetics Act) | Filed against the company by State of Bihar Through Hemant Kumar Pandit | Pending |
| District court, Ernakulam, Kerala | Criminal complaint | Filed against the company by an individual | Pending |
| High Court, HIMACHAL PRADESH | Court case (OMP) | Filed against the company by Janseen Pharmaceuticals and Ors(Not Applicable) | Pending |
| High Court, HIMACHAL PRADESH | Court case (OMP) | Filed against the company by Boehringer Ingelheim Pharma GMBH and Co. KG and Anr(Not Applicable) | Pending |
To see the full case history of Aeon Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aeon Formulations Private Limited has 18 MSME Form 1 returns on record between 2019 and 2024, listing 3,370 overdue payments to 93 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 93)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aries | |||
| an individual supplier | |||
| Kranal Prints | |||
| Hueman Graphics Private Limited | |||
| S V Prints |
To see the full MSME payment records of Aeon Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Aeon Formulations Private Limited has a workforce of 86 employees on its EPFO records as of Feb 18, 2025, across 1 active EPFO establishment.
Employee count
86
Active EPFO establishments
1
Employee growth
-6.52%
GST
Aeon Formulations has 7 GST registrations: 5 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
7
Active
5
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCA4128R1ZE | Tamil Nadu | Active | 01 Jul 2017 |
| 02AAHCA4128R1ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
| 34AAHCA4128R1ZC | Puducherry | Active | 01 Jul 2017 |
| 18AAHCA4128R1Z6 | Assam | Active | 02 Mar 2019 |
To see the full GST registrations and return filing status of Aeon Formulations Private Limited, buy the company report.
Recent activity
Aeon Formulations Private Limited has 13 board changes on record since 2009: 3 appointments and 10 cessations. The latest: Sathyamurthy Jayavardhini was appointed as Additional Director on 11 Apr 2025.
AGM
Aeon Formulations Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Appointed
Sathyamurthy Jayavardhini was appointed as Additional Director.
Filing
Aeon Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 06 Jan 2012 via Charge ID 10333251 with Canara Bank was fully satisfied on 27 May 2024.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100928092 was registered on 07 May 2024.
Charges
A charge with Canara Bank of Rs. 10.07 Cr registered on 06 Jan 2012 with Charge ID 10333251 was modified on 23 Mar 2023.
Ceased
Ariarasudhan Vaitheeswaran ceased to be Additional Director.
Ceased
Hasmukhlal Vora Dhirajlal ceased to be Director.
Appointed
Ariarasudhan Vaitheeswaran was appointed as Director.
Ceased
Vaitheeswaran Pachamuthu Aariappa ceased to be Director.
Ceased
Subramanian Suresh ceased to be Director.
Ceased
Vijayarani Vaitheeswaran ceased to be Additional Director.
10 earlier events are in the company report.
Frequently asked questions
Aeon Formulations is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 November 2008 (18+ years old) and is registered under CIN U33110TN2008PTC069867.
Aeon Formulations has 3 current directors:
- Vijayarani Vaitheeswaran - Director
- Ariarasudhan Vaitheeswaran - Director
- Sathyamurthy Jayavardhini - Additional Director
The latest financial statements of Aeon Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aeon Formulations is 33AAHCA4128R1ZE, registered in Tamil Nadu. The company has 7 GST registrations in all, of which 5 are active and 2 are cancelled or inactive. Other active GSTINs include 02AAHCA4128R1ZJ (Himachal Pradesh), 34AAHCA4128R1ZC (Puducherry), 18AAHCA4128R1Z6 (Assam).
The CIN (Corporate Identification Number) of Aeon Formulations is U33110TN2008PTC069867. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aeon Formulations has 40 court cases on record: 22 filed by the company and 18 filed against it. 16 are pending. Most are in the district courts.
Aeon Formulations was incorporated on 17 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Aeon Formulations by revenue are MRHM Pharma Private Limited, Sunberg Life Sciences Private Limited, Axon Drugs Private Limited, Kemecos India Pvt Ltd, Axacus Pharma Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sathyamurthy Jayavardhini was appointed as Additional Director on 11 Apr 2025. Ariarasudhan Vaitheeswaran ceased to be Additional Director on 21 Nov 2020. Hasmukhlal Vora Dhirajlal ceased to be Director on 31 Mar 2020. Aeon Formulations has 13 board changes on record in total.
Yes, Aeon Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0023186).
Aeon Formulations has 18 MSME Form 1 returns on record between 2019 and 2024, listing 3,370 overdue payments to 93 micro and small suppliers. The latest return was filed on 27 Apr 2024.
Aeon Formulations can be reached through the website aeonf.com. Its registered office is in Chennai, Tamil Nadu, India.